Published in Medical Letter on the CDC and FDA, October 13th, 2002
New analysis from Frost & Sullivan, World Electronic Regulatory Document Markets for Life Sciences, reveals that this industry generated revenues totaling $436.7 million in 2001.
"As the FDA and world regulatory bodies move away from text-heavy review formats toward the CTD, electronic publishing software developers are pushing aggressively to include modules specific to a CTD-type...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.